scholarly journals Mediastinal lymph node dissection in surgical treatment for early stage non-small-cell lung cancer: lobe-specific or systematic?

2017 ◽  
Vol 9 (9) ◽  
pp. 2728-2731 ◽  
Author(s):  
Hiroyuki Adachi ◽  
Takamitsu Maehara ◽  
Haruhiko Nakayama ◽  
Munetaka Masuda
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Surgical Treatment ◽  
Small Cell Lung Cancer ◽  
Lymph Node Dissection ◽  
Early Stage ◽  
Mediastinal Lymph Node ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung

Surgical outcomes of early-stage small-cell lung cancer: single-center experience

2019 ◽  
Vol 27 (3) ◽  
pp. 187-191
Author(s):  
Muhammet Sayan ◽  
Merve Satir Turk ◽  
Ali Celik ◽  
Ismail Cuneyt Kurul ◽  
Abdullah Irfan Tastepe
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Small Cell Lung Cancer ◽  
Lymph Node Dissection ◽  
Cell Lung Cancer ◽  
Early Stage ◽  
Mediastinal Lymph Node ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung

Background Small-cell lung cancer is a highly aggressive and metastatic epithelial lung malignancy. A small percentage of these tumors can be detected at an early stage and may be appropriate for surgical treatment. We analyzed the data of patients with early-stage small-cell lung cancer who underwent lobectomy and mediastinal lymph node dissection. Methods Between January 2011 and December 2016, 26 patients with early-stage small-cell lung cancer underwent lobectomy and mediastinal lymph node dissection and were included the study. The mean age was 60.9 years and 18 (69.2%) were male. Patients with increased uptake of 18 F-fludeoxyglucose in mediastinal or distant organs on positron-emission tomography computed tomography, or lung resections other than lobectomy, were not included in the study. Results The most common tumor location was the right upper lobe. The diagnoses were achieved by intraoperative frozen section study in almost all patients (92.3%). Mean overall survival was 58.5 ± 6.7 months (range 45–71 months) and the 5-year survival rate was 53%. We found that a statistically significant correlation between lymph node metastasis in N1 or N2 stations and survival. There was also a significant relationship between N2 nodal metastasis and recurrence. Conclusion As stated in the current guidelines, lung lobectomy and mediastinal lymph node resection should be considered in early-stage small-cell lung cancers. Survival outcomes of surgery for early-stage small-cell lung cancer are similar to the results in non-small-cell lung cancer.

Mediastinal lymph-node dissection in the surgical treatment of non-small cell lung cancer. Is it still worthwhile?

Lung Cancer ◽  
2003 ◽  
Vol 39 (1) ◽  
pp. 109-110 ◽  
Author(s):  
Stefano Margaritora ◽  
Alfredo Cesario ◽  
Venanzio Porziella ◽  
Pierluigi Granone
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Surgical Treatment ◽  
Small Cell Lung Cancer ◽  
Lymph Node Dissection ◽  
Cell Lung Cancer ◽  
Mediastinal Lymph Node ◽  
Small Cell ◽  
Node Dissection ◽  
Small Cell Lung

scholarly journals EXTENT OF MEDIASTINAL LYMPH NODE DISSECTION FOR CLINICAL T1 NON-SMALL CELL LUNG CANCER

2005 ◽  
Vol 51 (1) ◽  
pp. 33-40 ◽  
Author(s):  
KOICHI FUJIU ◽  
RYUZO KANNO ◽  
HIROYUKI SUZUKI ◽  
YUTAKA SHIO ◽  
MITSUNORI HIGUCHI ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Small Cell Lung Cancer ◽  
Lymph Node Dissection ◽  
Cell Lung Cancer ◽  
Mediastinal Lymph Node ◽  
Small Cell ◽  
Mediastinal Lymph Node Dissection ◽  
Node Dissection ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document